Clinical Trial Update: PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of PTC299 for HIV-related Kaposi's sarcoma was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• PTC299

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Kaposi's Sarcoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-03-05